1. Home
  2. NRIX vs GRBK Comparison

NRIX vs GRBK Comparison

Compare NRIX & GRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$14.76

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Green Brick Partners Inc.

GRBK

Green Brick Partners Inc.

SELL

Current Price

$59.92

Market Cap

2.6B

ML Signal

SELL

Company Overview

Basic Information
Metric
NRIX
GRBK
Founded
2009
2006
Country
United States
United States
Employees
N/A
620
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
NRIX
GRBK
Price
$14.76
$59.92
Analyst Decision
Buy
Analyst Count
14
0
Target Price
★ $33.50
N/A
AVG Volume (30 Days)
★ 3.4M
270.8K
Earning Date
10-12-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
3.26
★ 4.44
Revenue
$76,987,000.00
★ $2,098,471,000.00
Revenue This Year
$786.93
N/A
Revenue Next Year
N/A
$0.16
P/E Ratio
★ $4.52
$13.50
Revenue Growth
★ 99.31
N/A
52 Week Low
$12.61
$59.12
52 Week High
$28.23
$83.18

Technical Indicators

Market Signals
Indicator
NRIX
GRBK
Relative Strength Index (RSI) 25.08 40.42
Support Level $14.65 N/A
Resistance Level $17.47 $74.40
Average True Range (ATR) 1.22 2.40
MACD -0.77 -0.25
Stochastic Oscillator 0.23 1.31

Price Performance

Historical Comparison
NRIX
GRBK

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment, which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgages and title.

Share on Social Networks: